careers investors newsroom suppliers alumni login worldwide ELI LILLY AND COMPANY home about responsibility products r & d KEY FACTS HERITAGE KEY FACTS Impact On Indiana GLOBAL BUSINESS AREAS BOARD OF DIRECTORS EXECUTIVE COMMITTEE CORPORATE GOVERNANCE BUSINESS PRACTICES KEY ISSUES DIVERSITY LILLY FOUNDATION LILLY GRANT OFFICE LILLY AT A GLANCE A heritage more than 135 years strong: company founded on May 10, 1876 Headquarters located in Indianapolis, Indiana, U.S.A. Approximately 39,000 employees worldwide More than 7,900 employees engaged in research and development Clinical research conducted in more than 55 countries Research and development facilities located in eight countries Manufacturing plants located in 13 countries Products marketed in 125 countries Employees (as of September 30, 2014) Indianapolis: 10,735 Indiana (excluding Indianapolis): 1,030 U.S. (excluding Indiana): 5,412 Outside U.S.: 22,334 Worldwide total: 39,511 RELATED: Careers Financials - 2013 (dollars in millions, except per-share data) Net sales: $23,113.1 Net income as reported: $4,684.8 Earnings per share as reported: $4.32 Dividends paid per share: $1.96 RELATED: Investors R&D 2013 Expenditures $5,531 million/year $461 million/month $106 million/week $21 million/workday Increase from previous year: 5% R&D as a percentage of sales: 23.9% Employees engaged in R&D Activities: 8,069 Percentage of total workforce: 20% RELATED: R&D Cost of New Pharmaceuticals Average cost to discover and develop a new drug: $800 million to $1.2 billion Average length of time from discovery to patient: 10 to 15 years RELATED: Products Awards Lilly highly values the recognition and praise it receives from third parties for our continuing record and commitment to diversity and inclusion. Copyright © 2021 Eli Lilly and Company. All rights reserved. terms of use privacy sitemap contact